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Abstract: Recent studies have suggested that Mentha longifolia L. extracts (ME) have anti-inflammatory and antioxidant 
activities. In this paper, we attempted to determine the effect of ME in a rat stroke model. Five groups of experimental 
animals were used (n=14); the first and second groups (control and sham, respectively) received intraperitoneal injections 
of daily-distilled water; the other three groups received 50, 100, and 200 mg/kg/day of ME for 21 days. Two hours after the 
last dose, each group was subdivided into a middle cerebral artery occlusion (MCAO) group operated for neuropathological 
assessment (neurologic deficit scores, infarct volume, brain edema, and blood–brain barrier (BBB) permeability), and an 
intact subgroup for the assessment of brain and serum antioxidant capacity and lipid peroxidation, respectively. Pretreat-
ment with ME resulted in a significant reduction in total infarct volume, brain water content and Evans Blue extravasation 
in the ischemic hemisphere compared with the control. ME in doses of 100 and 200 mg/kg/day increased brain antioxidant 
capability in comparison with the control. The antioxidant capacity of the serum in the 100 mg/kg/day group was signifi-
cantly higher than that of the control group. The level of malondialdehyde (MDA) in the brain was significantly elevated in 
the control group in comparison with other pretreated groups. Moreover, ME in doses of 100 and 200 mg/kg/day reduced 
the MDA level in the serum. This study showed that intraperitoneal injection of ME reduced infarct volume, brain edema, 
blood-brain barrier permeability, as well as lipid peroxidation, and improved antioxidant power.
Key words: Cerebral ischemia; Mentha longifolia L. extract; malondialdehyde; neuroprotection; pretreatment.
Received: January 15, 2015; Revised: May 18, 2015; Accepted: May 19, 2015
INTRODUCTION
Transient brain ischemia is characterized by hypoxia 
during a short period of time followed by a period 
of hyperperfusion of the tissue with well-oxygenat-
ed blood. The reperfusion produces a considerable 
amount of free radicals in the tissue, which damage 
macromolecules, including proteins, nucleic acids and 
cell membranes. The pathophysiological end result is 
variable depending on the affected cell organelles or 
macromolecules (Beckman et al., 1990). The increased 
intracellular calcium levels cause cell death by vari-
ous mechanisms, including activation of proteases and 
lipases, formation of free radicals, lipid peroxidation 
and formation of nitric oxide (NO) and arachidonic 
acid. The production of a high level of NO may result 
in the production of high levels of free radicals, which 
damage principal biomolecules and include mem-
brane lipids, enzymes, and DNA (Dawson et al., 1991). 
When reperfusion occurs and oxygenation is restored, 
even further damage can be caused because of the gen-
eration of reactive oxygen species (ROS), which in-
cludes e.g. superoxide, hydroxyl radicals and hydrogen 
peroxide generated as side products in mitochondrial 
ATP synthesis. When oxygenation is restored, reactive 
oxygen species accumulate and cause damage to cel-
lular macromolecules (Karolinska, 2007).
Phenolics are defined as a class of polyphenols 
that are important secondary metabolites in plants 
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(Williams et al., 2004). Based on their C-skeleton, 
polyphenols are classified as flavonoids and phenolic 
acids (Williams et al., 2004). These compounds have 
antioxidant action and exert various beneficial effects 
in a multitude of diseases (Shirzad et al., 2011; Kabiri 
et al., 2013). Flavonoids are known to inhibit lipid 
peroxidation, platelet aggregation, capillary perme-
ability and fragility, cyclooxygenase and lipoxygenase 
enzyme activities. They exert these effects as antioxi-
dants, free radical scavengers and chelators of divalent 
cations (Cook and Samman, 1996; Hosseinpour et 
al., 2013; Rafieian-Kopaie and Baradaran, 2013). The 
powerful antioxidant activities of flavonoids against 
free radicals are attributed to their hydrogen-donating 
ability (Rafieian-Kopaie, 2012). It has been proposed 
that plant antioxidants can prevent or improve brain 
injury due to ischemia/reperfusion. It is therefore es-
sential to study the effects of antioxidants, free radi-
cal scavengers, or trapping agents for use as potential 
cerebroprotective agents of various brain injuries, in-
cluding ischemia/reperfusion-mediated brain injury 
(Baradaran et al., 2012). 
Mentha longifolia L. has medicinal and aromatic 
properties (Gulluce et al., 2007). It grows wild in vari-
ous regions of Iran (Omidbaigi, 2005) and has been 
used in Iranian traditional medicine as a stomach 
pain-relieving, antispasmodic, digestive and carmina-
tive agent (Zargari, 1990). Aerial parts of M. longifolia 
possess medicinal properties. The extract of Mentha 
species has been reported to have fungicidal, anti-
inflammatory, antimicrobial and antioxidant activi-
ties (Mimica-Dukic et al., 2003; Gulluce et al., 2007; 
Mkaddem et al., 2009).
Stanisavljevic et al. (2012) showed that the highest 
content of phenolic compounds in Mentha longifolia L. 
was found in the extract obtained from naturally dried 
plant materials. The dominant phenolic component 
in this extract was kaempferol 3-O-glucoside and the 
highest value of antioxidant activity was found in the 
extract obtained from the naturally dried herbs.
Kaempferol (3, 4ʹ,5,7-tetrahydroxyflavone) is one 
of the most commonly found dietary flavonols, the 
biological and pharmacological effects of which may 
depend upon its behavior as either an antioxidant 
or a prooxidant (Leung et al., 2007). Based on these 
results, it may be concluded that Mentha longifolia 
L. extract is a well-recognized source of secondary 
metabolites, like flavonoids, which are considered as 
an excellent antioxidant.
However, the neuroprotective effect of ME on 
ischemia/reperfusion-induced brain injury has not 
been evaluated thus far. Hence, this study was de-
signed to examine the effect of pretreatment with 
various doses of intraperitoneal injections of ME in 
the rat model of transient focal cerebral ischemia on 
brain infarct volume, brain edema and blood-brain 
barrier (BBB) permeability. In addition, the impact 
of intraperitoneal injection of ME on the total anti-
oxidant capacity of the brain and serum, as well as 




Aerial parts of M. longifolia were collected at the full 
flowering stage from the city of Shahrekord, Chaha-
rmahal and Bakhtiari Province, Iran, and dried in 
shade for 14 days. The plant was authenticated in the 
Herbarium Center of the Shahrekord University of 
Medical Sciences (Shahrekord, Iran). Fifty g of dried 
herbal materials was chopped into small pieces and 
macerated in 250 ml ethanol (80 v/v) for 2 days. Then, 
it was filtered and evaporated on a rotary evaporator 
at 40°C. The extract was dried in an oven at 37°C un-
til constant mass and kept in well-sealed glass vessels 
in a dry, cold and dark place.
Animals
Male Wistar rats, weighing 300-350 g, were used for 
the study. The rats were obtained from the Central 
Animal House of Shahid Beheshti University, Iran. 
Experiments were carried out in accordance with the 
official regulations approved by Animal Ethics Com-
mittee of Shahrekord University of Medical Sciences.
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Experimental protocol
Four main groups of animals (n=14 per group) re-
ceived intraperitoneal injections of different doses of 
plant extract (50, 100, and 200 mg/kg/day, between 
10:00 and 11.00 am) for 21 days. These doses were 
identified using previously published data (Hossein-
zadeh et al., 2011). A control group received the same 
volume of distilled water. Two hours after administra-
tion of the last dose, each group was subdivided into a 
middle cerebral artery occlusion (MCAO) group that 
subsequently underwent neuropathological assess-
ment (neurologic deficit scores, infarct volume, brain 
edema and BBB permeability), and intact subgroups 
for assessing antioxidant capacity and lipid peroxi-
dation of the brain and serum, respectively. Animals 
from a sham-operated group (n=7) underwent surgi-
cal procedure but without MCAO.
Ischemia induction
Middle cerebral artery occlusion was induced as de-
scribed by Longa et al. (1989) with minor modifi-
cations. The rats were weighed and anesthetized by 
intraperitoneal injection of a mixture of ketamine 
(60 mg/kg) and xylazine (6 mg/kg). Briefly, the right 
common carotid artery, external carotid artery and 
internal carotid artery were isolated through a ventral 
midline incision. A 3-0 nylon monofilament, with its 
tip rounded by heating near a flame, was introduced 
through the external carotid artery stump. The oc-
clude was advanced to the internal carotid artery 
20-22 mm beyond the carotid bifurcation until mild 
resistance indicated that the tip was lodged in the 
anterior cerebral artery and blocked the blood flow 
to the middle cerebral artery. One hour after middle 
cerebral artery occlusion, reperfusion was started by 
withdrawing the suture. Body temperature of the ani-
mals was maintained at 37°C by surface heating and 
cooling during the surgery. 
Assessment of neurobehavioral impact
After the suture was withdrawn, the rats were re-
turned to their separate cages. Twenty four h later, 
the rats were evaluated neurologically by an observer 
blind to the animal groups. The neurobehavioral 
scoring was performed using a six-point scale as pre-
viously described (Longa et al., 1989): normal motor 
function=0; flexion of contra-lateral forelimb upon 
suspension vertically by tail or failure to extend fore-
paw=1; circling to the contra-lateral side, but nor-
mal posture at rest=2; loss of righting reflex=3; no 
spontaneous motor activity=4. Death with the score 5 
was only considered when a large infarct volume was 
present in the absence of subarachnoid hemorrhage. 
If the rats died due to subarachnoid hemorrhage or 
pulmonary insufficiency and asphyxia, they were 
eliminated from the study.
Measurement of infract volume
After decapitation, the brains were quickly removed, 
placed in saline at 4°C for 15 min, and then cut into 
seven 2-mm coronal slices in a rodent brain matrix 
(RBM 4000C; Activational Systems, Warren, MI, 
U.S.A.). The slices were immersed in 2% solution of 2, 
3, 5-triphenyltetrazolium chloride (Merck, Germany) 
and kept at 37°C in a water bath for 15 min. The slices 
were then digitally photographed (Lumix-Panasonic 
camera, Japan, connected to a computer). Unstained 
areas were defined as infarct and measured using im-
age analysis software (UTHSCSA Image Tool). The 
infarct volume was calculated by measuring the un-
stained and stained areas in each hemisphere slice, 
multiplying by slice thickness (2 mm), and then sum-
ming all seven slices. To compensate for brain swell-
ing in the ischemic hemisphere (Swanson et al., 1990), 
infarct volume was corrected in each rat by comput-
ing the volume of the left and right hemispheres and 
applying the following formula: corrected infarct vol-
ume = left hemisphere volume − (right hemisphere 
volume−infarct volume).
Assessment of brain water content
After decapitation, the brains were removed, the cere-
bellum, pons and olfactory bulbs were separated, and 
their wet weights (WW) were measured (Bigdeli et al., 
2007). After drying in a desiccating oven at 120°C for 
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24 h, dry weights (DW) were assessed. Brain water 
content (BWC) was expressed as percent H2O, which 
was calculated using [(WW−DW)/WW] ×100.
Evaluation of BBB permeability
BBB disruption was measured as a function of Evans 
Blue (EB, Sigma Chemicals, USA) extravasation. BBB 
is normally impermeable to Evans Blue, which can 
only cross the barrier when it is disrupted. Briefly, 
the rats received 4 ml/kg of 2% EB solution in saline 
by tail vein injection 30 min after MCAO. Twenty-
four h after reperfusion, each rat was transcardia-
cally perfused with 250 ml of physiological saline 
under anesthesia. After decapitation, the brains were 
removed and the hemispheres were separated and 
weighed. The right and left hemispheres were sepa-
rately homogenized in 2.5 ml of phosphate-buffered 
saline to extract the EB; to precipitate protein; 2.5 ml 
of 60% trichloroacetic acid was added and mixed by 
vortex for 3 min. The samples were then placed at 
4°C for 30 min and centrifuged for 30 min at 1000 g. 
The absorbance was read at 610 nm by a spectropho-
tometer (Perkin-Elmer, Illinois, USA). EB levels were 
expressed as ng/g of brain tissue against a standard 
curve (Bigdeli et al., 2007).
Determination of antioxidant power in the brain 
and serum
Antioxidant power of the brain or serum was deter-
mined by measuring the ability to reduce Fe3+ to Fe2+, 
referred to as the ferric reducing antioxidant power 
(FRAP) test (Heidarian et al., 2013a). For assessing 
antioxidant power in the brain, the animals were de-
capitated and the brains were rapidly removed from 
the dead animals within 30 s from decapitation and 
immersed in liquid nitrogen. After weight determi-
nation, they were homogenized in the buffer (3 g 
Tris base in 450 ml dd H2O, 38.52 g sucrose, 186 mg 
EDTA (ethylene diamine tetra acetic acid) and scaled 
up to 500 ml with dd H2O, pH=7.4). The homogenate 
was centrifuged (10 min at 4000 rpm) and the super-
natant was then separated. The reagents included 300 
mM acetate buffer solution (pH=3.6) with 16 ml of 
acetic acid per 1 l of buffer solution, 10 ml of TPTZ 
(2,4,6-tripyridyl-s-triazine) in 40 mM HCl and 20 
mM FeCl3. Working FRAP reagent was prepared as 
required by mixing 25 ml of acetate buffer, 2.5 ml of 
TPTZ solution and 2.5 ml of FeCl3. Fifty μl of super-
natant was added to 1.5 ml of freshly prepared reagent 
warmed at 37ºC. After 10 min, the complex between 
Fe2+ and TPTZ had a blue color with absorbance at 
593 nm. Data were expressed as μM per g of wet tis-
sue. For assessing antioxidant power in the serum, 
fifty μl of serum was added to 1.5 ml of freshly pre-
pared FRAP reagent warmed at 37ºC. After 10 min, 
the complex between Fe2+ and TPTZ had a blue color 
with absorbance at 593 nm. Data were expressed as 
μM per l of serum.
Assessment of lipid peroxidation  
in the brain and serum
Analysis of malondialdehyde MDA by the thiobarbi-
turic acid (TBA) assay has been widely employed, ini-
tially as a measure of rancidity in food and in biologi-
cal systems for assessing lipid peroxidation (Heidarian 
and Rafieian-Kopaei, 2013). We used the TBA to as-
sess the ischemia/reperfusion damage. TBA is a spec-
trophotometric assay based upon sample heating un-
der acidic conditions to form an adduct MDA-(TBA)2. 
Specificity of the assay has been questioned, and 
high-performance liquid chromatography (HPLC) 
of the MDA-(TBA)2 complex has been introduced 
to improve the specificity of the reaction (Bird et al., 
1983). For assessing lipid peroxidation in the brain, 
the animals were decapitated and the brains were rap-
idly removed from the dead animals within 30 s from 
decapitation and immersed in liquid nitrogen. After 
weight determination, they were homogenized in the 
buffer (3 g Tris base in 450 ml dd H2O, 38.52 g su-
crose, 186 mg EDTA and scaled up to 500 ml with dd 
H2O, pH=7.4). The homogenate was centrifuged (10 
min at 4000 rpm) and the supernatant was separated. 
The TBA assay in the brain was adapted from Heidar-
ian et al. (2013b). The optimized TBA assay was as 
follows: 100 µl of supernatant was treated with 10 µl 
of 0.5 M BHT (butylated hydroxytoluene) (in absolute 
ethanol) followed by the addition of 200 µl of 8.1% 
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SDS (sodium dodecyl sulfate) and 1.5 ml of 0.8% TBA 
(0.8 g TBA, 19 ml of 20% acetic acid, and scaled up 
to 100 ml with dd H2O, pH=3.5). Then, the samples 
were heated for 60 min in a boiling-water bath. After 
cooling to 4°C, 3 ml of butanol-pyridine was added to 
the samples and centrifuged at 4000 g for 10 min. Fi-
nally, an aliquot (120 µl) was directly injected into the 
HPLC. Data were expressed as μM per g of wet tissue.
Serum MDA was determined by TBA method as 
described by Asadi et al. (2013). In this assay, 50 µl of 
serum was treated with 50 µl 0.05% BHT (in absolute 
ethanol) followed by the addition of 400 µl 0.44 M 
H3PO4 (aqueous) and 100 µl 42 M TBA (aqueous), 
which was mixed by vortex. Then, the samples were 
incubated for 60 min at 100°C. After cooling at 4°C, 
250 µl of butanol-pyridine was added to the samples, 
vortexed, and centrifuged at 13000 g for 7 min. Fi-
nally, an aliquot (120 µl) was directly injected into 
the HPLC. Data were expressed as μM per l of serum.
HPLC separation
Separation of the MDA-(TBA)2 adduct was per-
formed using the automated WatersTM HPLC system 
(510 Pump,717 Autosampler and 486 Detector (at 532 
nm), driven by the Millennium 2010 Chromatography 
Manager software (Waters Ltd., Watford, Hertford-
shire, England). The analytical column was a reverse 
phase silica-based C18 column (Spherisorb 5ODS 2, 
HPLC Technology Ltd. (Warrington, Cheshire, Eng-
land)) with the column dimensions of 25 cm×4.6 mm 
and a C8 guard column (HPLC Technology Ltd.). The 
elution buffer was determined to be 50 mM KH2 PO4-
KOH, pH=7.0, 35% methanol, which was degassed 
under vacuum through a 0.45-µM filter (Millipore, 
type HAWP). The sample run was 10 min with a ﬂow 
rate of 1.2 ml/min, injection volume of 120 µl and visi-
ble detection of 532 nm. All the standards and samples 
were run and data were analyzed automatically using 
the Millennium software package. The mean peak area 
was determined for each sample run in duplicate and 
the levels of MDA were calculated directly from the 
calibration of the TEP (1,1,3,3-tetraethoxypropane) 
standards (Heidarian et al., 2013b).
Determination of the antioxidant  
activity of the extracts
The free radical scavenging activity of ME was meas-
ured by DPPH (2,2-diphenyl-1-picrylhydrazyl) radical 
using Heidarian and Rafieian-Kopaei’s (2013) method. 
Briefly, a 0.1-mM solution of DPPH in methanol was 
prepared and 2 ml of this solution was added to 2 ml 
of the sample solution of the extract in methanol at 
different concentrations (10-100 μg/ml). After 15 min 
of incubation at room temperature in the dark, the 
absorbance was measured at 517 nm. BHT was used 
as a positive control. The control was prepared like the 
test samples and methanol was used for baseline cor-
rection. Inhibition of free radicals by DPPH (%) was 
calculated using the following formula:
Inhibition of free radical by DPPH (%) =
 
where A0 is the absorbance of the control reaction 
and A1  is absorbance in the presence of the standard 
sample or extract.
Determination of total phenol contents
The total phenol content in the extracts was deter-
mined according to the Folin-Ciocalteu (FC) reagent 
(Sharafati et al., 2011) using gallic acid (GA) as the 
standard. The extract solution in 70% ethanol (0.2 ml, 
1 mg/ml) was mixed with the FC reagent (1 ml) and 
aqueous solution of Na2CO3 (0.8 ml, 7.5%). After 30 
min of incubation at room temperature, the absorb-
ance of the reaction compound at 765 nm was meas-
ured by spectrophotometer. The overall phenol con-
tent was expressed as mg of gallic acid/g of extract and 
calculated using the equation of the standard curve.
Determination of total flavonoid contents
The total flavonoid content in the extracts was de-
termined by spectrophotometry, based on the pro-
duction of complex compounds of flavonoids with 
aluminum chloride (Quettier et al., 2000). Each plant 
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extract (2.0 ml, 1.0 mg/ml) in 70% ethanol was mixed 
with 0.10 ml of 10% aluminum chloride, 0.10 ml of 
(1.0 M) potassium acetate and 2.8 ml of distilled wa-
ter. After 30 min of incubation at room temperature, 
the absorbance of the reaction mixture was measured 
at 415 nm in relation to distilled water. Rutin (RU) 
was chosen as the standard and the total flavonoid 
content was expressed as mg of rutin/g of extract and 
counted using the equation of the standard curve.
Statistical analysis
Graph Pad Prism 5.0 (Graph Pad Software Inc., Cali-
fornia, USA) software was used to analyze the data 
and the results were expressed as mean±SEM. All 
the variables, except the neurological score, were 
analyzed using one-way ANOVA and post-hoc LSD. 
The neurologic deficit scores were analyzed using 
Mann-Whitney U test. Differences were considered 
statistically significant at p<0.05.
RESULTS
Assessment of free radical scavenging activity
The free radical scavenging effect is defined as the 
amount of antioxidant necessary to decrease the ini-
tial DPPH radical concentration by 50% (IC50). IC50 
indicates the potency of scavenging activity. In this 
investigation, BHT was found to have the IC50 of 
35.64±0.76 μg/ml. Compared to BHT, ME showed 
an IC50 of 62.27±0.72 (Table 1). 
Content of total phenols and flavonoids in the extract
The total phenol content in the examined extract was 
112.17±1.9 mg of GA/g of extract, while the concen-
tration of total flavonoid in the plant extract from ME 
was 89.71±0.5 mg RU/g of extract (Table 2).
Effects of ME on neurologic deficit scores
Median neurologic deficit scores (NDS) were reduced 
by ME, and were as follows: 1 (range: 0-4), 0 (range: 
0-2), 1 (range: 0-4), and 2 (range: 2-4) in the 50, 100 
and 200 mg/kg/day and control groups, respectively 
(Table 3). Putative beneficial effects of ME were con-
firmed by a reduction in infarct volume (Fig. 1). 
Effects of ME on infarct volume
Pretreatment with 100 mg/kg/day ME for 21 days 
and 2 h before MCAO resulted in the reduction of 
total infarct volume (p=0.04), while lower and higher 
doses (50 and 200 mg/kg/day, respectively) had no ef-
fects (Fig.1). The neuroprotection exerted by ME was 
mainly seen in the penumbra (cortex), while slightly 
observed in the infarct core. Beside pretreatment with 
50 and 200 mg/kg/day, ME reduced infarct volume in 
the penumbra but not in core (p=0.001 and p=0.000, 
respectively).
Effects of ME on brain edema
Focal cerebral ischemia resulted in a significant in-
crease in the brain water content of the ischemic hemi-
sphere in the control compared with the sham group 
(p=0.004). Pretreatment with ME in a dose of 100 mg/
kg/day for 21 days and 2 h before MCAO induced a 
statistically significant (p=0.024) reduction in brain 
water content in the ischemic hemisphere, while in the 
other groups (50 and 200 mg/kg/day) it had no effects. 
In addition, the brain water content of the ischemic 
and non-ischemic hemispheres in the control group 
was significantly different (p=0.029) (Fig. 2). 







Each value is the mean ± standard error.
Table 2. Total phenol and flavonoid contents in the M. longifolia 
extract.
Sample Total phenol (mg of 
GA/g of extract)
Total flavonoid (mg 
of RU/g of extract)
M. longifolia 
extract 112.17±1.9 89.71±0.5
Each value is the average of three analyses ± standard errors.
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Effects of ME on BBB permeability
Brain edema formation was associated with increased 
BBB permeability at 24 h. In the control group, EB con-
centration in ischemic cerebral tissue was 85.98±9.93 
and 59.85±4.52 ng/g tissue in the non-ischemic left 
hemisphere. Pretreatment with 50, 100 and 200 mg/kg/
day of ME was associated with the significant reduc-
tion in EB extravasation in the ischemic hemisphere 
compared with the control group (p=0.001, p=0.000, 
and p=0.002, respectively). BBB permeability was not 
significantly higher in the ischemic right hemisphere 
scale compared to the non-ischemic left hemisphere in 
the groups pretreated with ME (Fig. 3).
Table 3. Distribution of neurologic deficit score in each group.
Statistical results (P value) Median Total (N) NDS in each group Experimental groups No
4 3 2 1 0
1:3 sig (0.008) 2 7 1 0 6 0 0 Control (dose 0) 1
1:2, 1:4, 2:3, 2:4 and 3:4 nonsig
1 7 1 0 2 1 3 Dose 50 2
0 7 0 0 2 1 4 Dose 100 3
1 7 1 0 2 3 1 Dose 200 4
- 28 3 0 12 5 8 Total (n) -
NDS: Neurologic deficit score; n: Number of cases per group; sig: Significant; nonsig: Non-significant
Fig. 1. (a) Photographs showing the neuroprotective effect of M. longifolia extract (ME) on focal cerebral isch-
emia. All the sections of the brain were stained with TTC 24 h after 60 min of ischemia. Each column represents 
the series of rat brain coronal sections: (1) Brain sections of control rats; (2), (3), and (4) brain sections of rats 
pretreated with 50, 100 and 200 mg/kg/day of ME, respectively. (b) The graph shows the effects of various doses 
(control, 50, 100 and 200 mg/kg) of ME on total  infarct volume in different experimental groups (*p<0.05; n=7).
Fig. 2. Brain water content in the left and right hemisphere of 
control, sham-operated and groups pretreated with 50,100 and 
200mg/kg/day of ME (*p<0.05; **p<0.01; n=7).
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Effects of ME on brain and serum antioxidant 
capacities
In the brain, antioxidant capacity was significantly 
decreased in the control group compared with sham-
operated animals (p=0.000). Extract of M. longifolia 
at the doses of 100 and 200 mg/kg/day increased anti-
oxidant capacity in the brain (p=0.000 and p=0.001; 
respectively) compared with the control group. At the 
dose of 50 mg/kg/day, the extract did not significantly 
modify the brain’s antioxidant power (Fig. 4).
The antioxidant capacity of serum in the 100-mg/
kg/day group was significantly higher than that of the 
control group (p=0.01). Sham operation and pretreat-
ment with doses of 50 and 200 mg/kg/day of ME had 
no statistically significant impact on the antioxidant 
power of serum compared to the control group (Fig. 4).
Effects of ME on lipid peroxidation in the brain 
and serum
The MDA level in the brain was significantly elevated 
in the control compared with the sham group. Alter-
natively, pretreatment with all investigated doses of 
ME (50, 100 and 200 mg/kg/day) considerably low-
ered the brain level of MDA (p=0.001, p=0.000, and 
p=0.000, respectively). Moreover, the extract of M. 
longifolia at the doses of 100 and 200 mg/kg/day re-
duced the MDA level of serum (p=0.002 and p=0.002, 
respectively), while the lower dose (50 mg/kg/day) 
had no effect (Fig. 5). As in the brain, the serum 
MDA level was significantly elevated in the control 
compared to the sham groups (p=0.033).
DISCUSSION
The results of this study show that transient cerebral 
ischemia induces lipid peroxidation and decreases 
the antioxidant power of the brain, as previously 
Fig. 5. Effects of ME on brain and serum MDA levels in rats sub-
jected to transient cerebral ischemia. The extract was administered 
intraperitoneally at different doses of 50, 100 and 200 mg/kg/day. 
(*p<0.05; **p<0.01; ***p<0.001; n=7).
Fig. 3. EB extravasations in various experimental groups including 
left and right hemisphere of control, sham-operated, and groups 
pretreated with 50, 100 and 200 mg/kg/day of ME (*p<0.05; 
**p<0.01; ***p<0.001; n=7). 
Fig. 4. Effects of ME on brain and serum antioxidant power in 
rats subjected to transient cerebral ischemia. The extract was ad-
ministered intraperitoneally at different doses of 50, 100 and 200 
mg/kg/day. (*p<0.05; **p<0.01; ***p<0.001; n=7).
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described (Asgary et al., 2013a; Akbari et al., 2013; 
Calapai et al., 1993). Other studies have shown the 
neuroprotective property of ME by multi-mecha-
nisms, such as antioxidation and effects on the lipid 
metabolism (Gulluce et al., 2012; Lopes et al., 2010) 
Therefore, it can be speculated that ME might play 
a key role in the treatment of ischemic disorders of 
the cerebrovascular system. Pretreatment with ME 
markedly reduced the infarct size induced by MCAO 
and produced significant protection against neuronal 
damage. This effect was in harmony with other stud-
ies showing that antioxidant agents could reduce vari-
ous brain injuries, including ischemia/reperfusion-
mediated brain injury (Tanaka et al., 2007; Rabiei et 
al. 2014). Interestingly, we have shown that all doses 
of ME radically reduced the volume of ischemic pe-
numbra that surrounds the infarct core, which may 
contribute to the better neurological recovery no-
ticed in the ME-treated groups. Our observation is 
in agreement with the fact that there is a high correla-
tion between the extent of spontaneous neurological 
recovery and the volume of penumbra that escapes 
infarction (Guadango et al., 2003).
The beneficial effects of naturally occurring anti-
oxidants have been reported in rodent models of 
stroke. For example, pretreatment with antioxidants, 
such as vitamin E (Khanna et al., 2005), Ginkgo biloba 
extract and α-lipoic acid (Clark et al., 2001) reduced 
ischemic brain damage in rodents. The protective ef-
fects of antioxidants have been also reported in clinical 
observations. For example, the intake of an antioxi-
dant-enriched diet was associated with lower risk for 
cerebral infarction in male patients (Hirvonen et al., 
2000). Similarly, low antioxidant activity in plasma is 
associated with greater lesion volumes and neurologi-
cal impairments in stroke patients (Leinonen et al., 
2000). Taken together, these data suggest that com-
pounds that possess antioxidant properties can reduce 
ischemia-mediated neurodegeneration in the brain.
In the present study, the highest dose of ME (200 
mg/kg) had no better effect on median neurologic 
deficit scores (NDS) than the lower doses (50 and 
100 mg/kg). Pretreatment with 100 mg/kg/day of 
ME resulted in the reduction of total infarct volume 
(p=0.04), while the lower and higher doses (50 and 
200 mg/kg/day, respectively) had no such effects. Fo-
cal cerebral ischemia resulted in a significant increase 
in the brain water content of the ischemic hemisphere 
in the control compared with the sham and 100-mg/
kg/day groups; however, this was not the case in the 
50- and 200-mg/kg/day groups. Also, pretreatment 
with 100 mg/kg/day of ME had a better effect on BBB 
integrity in the ischemic hemisphere and the antioxi-
dant power of the brain and serum compared with 
the 200-mg/kg/day group. The lack of positive effect 
of 200 mg/kg/day was somewhat surprising, because 
100 mg/kg/day positively affected all the above-
mentioned examinations. The exact mechanism is 
not clear, but pro-oxidant activity of ME in high dose 
might have caused the reduced effect in this dose. In 
the sham group, surgery stress led to the production 
of antioxidant enzymes. These enzymes can increase 
antioxidant power and decrease lipid proxidation 
(Halliwell, 1994). Although antioxidants have been 
shown to possess protective effects on various diseas-
es such as diabetes (Bahmani et al. 2014; Asgary et al., 
2014), atherosclerosis (Mirhosseini etal., 2014; Asgary 
et al., 2013b), nephrotoxicity (Baradaran et al., 2013; 
Nasri et al., 2013), cardiovascular diseases (Khosravi-
Boroujeni et al., 2012; Sarrafzadegan et al., 2013), as 
well as brain ischemia, under certain circumstances, 
they may act as pro-oxidant inducing oxidative stress. 
It has been suggested that the pro-oxidant properties 
of antioxidants are mostly concentration-dependent. 
The generation of the superoxide anion radical and 
products of lipid peroxidation is increased with in-
creasing the concentrations of hesperetin, quercetin, 
naringenin or morin in human lymphocytes. Moreo-
ver, these compounds induce DNA strand breakage at 
high concentrations (Yen et al., 2003).
BBB selectively limits the passage of solutes to the 
brain, thereby maintaining homeostasis and protect-
ing the brain from toxins. Focal cerebral ischemic in-
jury results in the disruption of BBB in rodents (Yang 
et al., 1994), as well as in humans (Latour et al., 2004). 
The data presented in this study indicated that ME 
may influence brain water content and brain water 
homeostasis by directly increasing BBB integrity, 
modulating cell volume of neurons and astrocytes. 
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Mohagheghi et al. (2010) showed that pretreat-
ment with dietary virgin olive oil can reduce infarct 
volume, brain edema, BBB permeability and neurobe-
havioral deficit scores in a reliable and reproducible 
animal model of stroke followed by reperfusion. Oxi-
dative stress, via the increased production of ROS and 
lipid oxidation, induces inflammatory response. The 
primary reason for the particular vulnerability of the 
brain in cerebral ischemia is the fact that the inter- 
and intracellular signalling mechanisms crucial for 
the normal functions of the brain become harmful 
under ischemic conditions. In addition, energy failure 
is accelerated, enhancing the final pathways underly-
ing ischemic cell death, including free radical pro-
duction, activation of catabolic enzymes, membrane 
failure, inflammation and apoptosis (Centonze et al., 
2001). Lack of ATP causes the cells to enter a state of 
anoxic depolarization, which opens up voltage sensi-
tive ion channels and allows the pathological entry 
of calcium, sodium and chloride ions into the cells. 
Passive and excessive entry of water into the cells sub-
sequently results in cytotoxic edema (Siesjö, 1992).
M. longifolia phenols with high antioxidant capac-
ity can thus inhibit lipid oxidation and block inflam-
matory responses (Karimian et al., 2013). Flavonoids 
also have antiapoptotic activity. The fact that they in-
crease cell survival in an oxidative stress model where 
scavenging antioxidants fail to protect cells from the 
oxidative insult suggests that these molecules have a 
specific cell survival-increasing activity in addition 
to their scavenger activity. Cytoprotective capacity of 
flavonoids may be linked to their ability to activate 
intracellular molecules (kinases, phosphatases, gene 
promoters), which in turn activates the components of 
intracellular cascades and promotes the expression of 
survival signals. This issue would be specifically true 
for cellular protection in cases where apoptosis is an 
important component of cell death (Dajas et al., 2003).
This study was focused on the effects of ME on 
the antioxidant potential and lipid peroxidation, 
which are important in neuroprotection assessments. 
Although the mechanism of neuroprotection induced 
by ME requires further elucidation, it has been shown 
that polyphenolic compounds in ME exert their anti-
oxidant activities in the following ways: by giving out 
an H-atom, by directly connecting free oxygen and 
nitrogen radicals, by chelating prooxidant metal ions 
(Fe or Cu), and by inhibiting prooxidant enzymes 
(lipoxygenase, myeloperoxidase, xanthine oxidase, 
NAD(P)H oxidase, and cytochrome enzymes P-450) 
(Cook and Samman, 1996).
The presented experimental data showed that, in 
the brain, pretreatment with ME doses of 100 and 200 
mg/kg/day significantly increased antioxidant power 
in comparison with the control group. In addition, 
the antioxidant power of serum in the 100-mg/kg/
day group was significantly higher than in the control 
group. Compelling evidence implicates free radicals 
act as major contributors to ischemic and excitotoxic 
tissue injury in the CNS. The mechanisms of calci-
um-dependent free radical (FR) generation caused 
by ischemia reoxygenation injury might include xan-
thine/xanthine oxidase reaction and activation of NO 
or phospholipase A2 (Shaheen et al., 2009). 
The presented results show that there was a sig-
nificant decrease in the level of lipid peroxidation in 
the brain and serum after treatment with ME. The 
extract reversed the increase of MDA levels to a con-
siderable extent, thereby confirming its probable anti-
oxidant role in ischemia. Peroxidation of lipids is a 
binding process connected to the formation of MDA 
(Niedworok and Bielaszka, 2007), which has been uti-
lized as a suitable biomarker for lipid peroxidation 
(Atip et al., 2010). Besides, in the ischemic brain, a 
substantial elevation in the lipid peroxidation along 
with depletion in the activity of various protective 
antioxidant enzymes was observed, which could be 
validated by many earlier reports (Gupta et al., 2003; 
Sugawara and Chan, 2003). However, treatment with 
ME resulted in decreased MDA level and increased 
antioxidant power when compared with the control 
group, suggesting the decreased formation of ROS or 
radical scavenging activity of ME.
In another study, the protective role of oleuro-
pein, a phenolic compound present in olive leaf ex-
tract, in the midbrain of aged rats has been investi-
gated by Sarbishegi et al. (2013). The finding showed 
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that the lipid peroxidation level was decreased after 
oleuropein treatment in the experimental group, 
which could be due to the antioxidant effect of oleu-
ropein phenolic compounds. Researchers have sug-
gested that the MDA levels, as a result of lipid peroxi-
dation in damaging brain, are overestimated and one 
of the beneficial effects of oleuropein is the reduction 
of MDA in these patients. 
Since the antioxidant effects of some species of 
Pistacia have been reported (Weia et al., 2002), the 
protective effects of Pistacia vera L. gum extract on 
oxidative damage following cerebral ischemia were 
studied in rats. Phytochemical analysis revealed that 
the gum extract of P. vera had flavonoids, tannins and 
saponins. The MDA levels increased significantly 
following cerebral ischemia-reperfusion injury, but 
the extract reversed the increase of MDA levels to a 
considerable extent, confirming its antioxidant role 
in the ischemia. Researchers have also evaluated the 
antioxidant or reducing potential of hippocampus 
homogenate samples following ischemia reperfusion 
injury using FRAP assay. As expected, following the 
reperfusion, the extract increased the antioxidant 
power of homogenate samples of the hippocampus 
(Mansouri et al., 2005).
Phytochemical studies have revealed that ME 
has natural antioxidants such as flavonoids. Recently, 
the antioxidant properties of various flavonoids and 
related phenolic compounds have been studied ex-
tensively. In addition, antihypoxic and anti-ischemic 
activities have been reported for some of these com-
ponents (Calapai et al., 2000; Nishimura et al., 2000). 
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